RAYA DAVIS-GILES: Open Payments
NPI 1306519061 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 26 payments from 14 companies in 2025. Trend: 2023 $33 · 2024 $847 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $155 |
| ABIOMED | 1 | $150 |
| Janssen Pharmaceuticals, Inc | 2 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Novo Nordisk Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Abbott Laboratories | 2 | $39 |
| PFIZER INC. | 1 | $27 |
| Medtronic, Inc. | 1 | $25 |
Products named: SPRAVATO, QULIPTA, AIRSUPRA, MOUNJARO, FREESTYLE LIBRE 3, UBRELVY, SHINGRIX, ELIQUIS.
Industry payments across CA — which companies pay providers there.
